Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific SecureSette, a new cassette for histology laboratories that reduces embedding time by 50 percent. The innovative design of new SecureSette™ cassettes makes embedding extremely simple; tissues are orientated during grossing and the cassette is not opened during embedding. An integral sponge securely holds tissue in place during processing which not only improves orientation, but also reduces the time spent re-embedding incorrectly aligned samples by more than half. The result is a more efficient workflow, higher quality and improved patient safety without the need to purchase additional equipment.
SecureSette also enhances accuracy and improves specimen integrity by reducing cross-contamination. Even the most difficult specimens, such as multiple needle biopsies and skin cross-sections, can be securely processed with complete accuracy of orientation by embedding them in the same plane for ease of sectioning and diagnosis. Forceps are not required, which not only prevents cross-contamination, but also eliminates crushing artifacts.
In histology laboratories, embedding remains one of the most labor-intensive steps. With tissue orientation carried out by the most qualified scientist during grossing or cut-up, the Thermo Scientific SecureSette cassette simplifies the embedding process by maintaining the correct tissue position while enabling technologists to spend time on other tasks. This decreases the time required to present a finished slide to a pathologist.
SecureSette is the latest addition to the Thermo Scientific portfolio of histology workflow solutions. Combined with the Thermo Scientific PrintMate, the STP420 tissue processor or the Thermo Scientific SlideMate, accelerated embedding encourages lean workflows and error reduction. For further information, please visit www.thermoscientific.com/securesette.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.
Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies